Table 3.

Distribution of nosocomial infections registered cases in HIV/AIDS patients attended at University Hospital, Londrina, Paraná, from July 2003 to July 2004, according to gender, age, nosocomial permanence, topography, isolated microorganism, CD4+ T cell counts and clinical evolution.

Case	Gender	Age (years)	Nosocomial permanence (days)	Topography of infection	Isolated Microorganism	CD4+ T cell counts (cell/mm3)	Clinical evolution to death
1	F	26	145	Meningis	––	15	No
2	F	27	21	Urinary tract	E. coli	38	No
3	F	65	22	Lung	E. coli	25	Yes
4	M	40	06	Lung	––	––	Yes
5	F	36	36	Urinary tract Bloodstream	E. coli S. aureusa	13	Yes
6	F	38	82	Urinary tract Bloodstream	P. aeruginosa S. aureus a	203	Yes
7	F	27	19	Lung	––	216	No
8	M	60	17	Lung	––	––	No
9	M	58	17	Urinary tract Lung	P. aeruginosab S. aureusa	32	Yes
10	F	35	66	Lung Catheter	S. aureusa A. baumanii S. aureus a	23	Yes
11	M	35	08	Lung	––	313	Yes
12	M	31	59	Urinary tract Paranasal sinuses	E. faecalis	91	Yes
13	M	54	84	Lung	S. aureus K. ozanae	1	Yes
14	M	48	27	Urinary tract	P. aeruginosac	416	No
15	F	26	6	Lung	––	308	No
16	F	18	45	Perithoneum	––	336	No
17	M	62	36	Lung	––	113	No
18	M	44	39	Lung	P. aeruginosa c	216	No
19	M	54	42	Urinary tract Catheter	P. aeruginosa d S. aureus a	1	Yes
20	M	40	18	Bloodstream	K. pneumoniae e	802	Yes
21	F	28	21	Lung	––	300	Yes
22	M	34	11	Lung	––	1	Yes
23	F	32	31	Bloodstream	––	19	Yes
24	F	47	10	Lung	––	3	No
n=24	F=12 M=12	Mean 40.2	Mean 36.2	50.0% lung 25.0% mixed 8.3% urinary tract 4.1% perithoneum 4.1% meningis 8.3% bloodstream	50.0% of infections had an isolated microorganism 66.67% of them showed drug resistance phenotype	158.4±40.3* (n = 22)	50.4% dead

^aoxacilina resistant strain (ORSA)

^bbetalactamase producing strain

^ccarbapenase producing strain (CESP)

^dcarbapenase producing strain and resistant to the polimixina

^eextended spectrum betalactamase producing strain (ESBL)

^*average ± standard deviation; n = total considered; M = male; F = female; ––: no data available.